Lv1
30 积分 2022-03-28 加入
Parkinson disease therapy: current strategies and future research priorities
1个月前
已完结
Immolation of p-Aminobenzyl Ether Linker and Payload Potency and Stability Determine the Cell-Killing Activity of Antibody–Drug Conjugates with Phenol-Containing Payloads
1个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
2个月前
已完结
Recent Advances in the Linkers of Drug Conjugates
2个月前
已完结
Antibody–oligonucleotide conjugates enter the clinic
2个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
3个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
3个月前
已完结
THERAPEUTIC OLIGONUCLEOTIDES, IMPURITIES, DEGRADANTS, AND THEIR CHARACTERIZATION BY MASS SPECTROMETRY
5个月前
已完结
Impurities in Oligonucleotide Drug Substances and Drug Products
5个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
5个月前
已完结
皖公网安备34019202002308
